Casopitant 50 mg
Sponsors
GlaxoSmithKline
Conditions
Nausea and Vomiting, Chemotherapy-Induced
Phase 1
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]
CompletedNCT00404378
Start: 2006-10-20End: 2007-01-05Updated: 2017-09-12
A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults
CompletedNCT00460707
Start: 2007-04-16End: 2007-08-27Updated: 2017-08-03